Plowing through Transcriptional Variations by Harnessing...
New Screening and Diagnostic Tools that...
Oxitec, Agency Clash with Critics over...
The Single Cell Analysis Marketplace from...
For full access to this article login to GEN Select now.
Meet the big spenders, ranked by total R&D expenses. [© Melpomene - Fotolia.com]
For all the talk about biopharmas cutting back on research and development, more companies (12) actually increased their R&D spending in 2013 than decreased ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Are proposals to circumvent the usual mechanisms of federal funding realistic?
Be sure to add email@example.com
to your Address Book or Safe Senders List.
here for instructions.
If you have any questions about your subscription, click
here to email us or call at (914) 740-2189.
You may also be interested in subscribing to the GEN magazine, an indispensable
resource for everyone involved in the business of translating discoveries at the
bench into solutions that fight disease and improve health, agriculture, and the
today to see why over 60,000 biotech professionals read GEN to
keep current in the areas of genomics, proteomics, drug discovery, biomarker discovery,
bioprocessing, molecular diagnostics, collaborations, biotech business trends, and
© 2015 Genetic Engineering & Biotechnology News All Rights Reserved